- Home
- STTK vs NA Comparison
STTK vs NA Comparison
Compare STTK & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- NA
- Stock Information
- Founded
- STTK 2016
- NA 2019
- Country
- STTK United States
- NA China
- Employees
- STTK N/A
- NA N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- NA Semiconductors
- Sector
- STTK Health Care
- NA Technology
- Exchange
- STTK Nasdaq
- NA Nasdaq
- Market Cap
- STTK 83.8M
- NA 95.7M
- IPO Year
- STTK 2020
- NA 2022
- Fundamental
- Price
- STTK $2.14
- NA $5.01
- Analyst Decision
- STTK Hold
- NA
- Analyst Count
- STTK 6
- NA 0
- Target Price
- STTK $2.67
- NA N/A
- AVG Volume (30 Days)
- STTK 1.5M
- NA 233.0K
- Earning Date
- STTK 11-13-2025
- NA 08-15-2025
- Dividend Yield
- STTK N/A
- NA N/A
- EPS Growth
- STTK N/A
- NA N/A
- EPS
- STTK N/A
- NA N/A
- Revenue
- STTK $2,997,000.00
- NA $3,369,693.00
- Revenue This Year
- STTK N/A
- NA N/A
- Revenue Next Year
- STTK N/A
- NA N/A
- P/E Ratio
- STTK N/A
- NA N/A
- Revenue Growth
- STTK N/A
- NA N/A
- 52 Week Low
- STTK $0.69
- NA $2.77
- 52 Week High
- STTK $3.95
- NA $31.48
- Technical
- Relative Strength Index (RSI)
- STTK 58.93
- NA 45.83
- Support Level
- STTK N/A
- NA $4.77
- Resistance Level
- STTK $2.01
- NA $5.50
- Average True Range (ATR)
- STTK 0.21
- NA 0.43
- MACD
- STTK 0.01
- NA 0.06
- Stochastic Oscillator
- STTK 99.53
- NA 15.69
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.